Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.09.15.751936

DBL-1/BMP signaling pathway Smads and master transcription regulator BLMP-1/PRDM1 interact to regulate organismal traits in Caenorhabditis elegans

Lakdawala, M. F.·Madhu, B.·Shaji, S.·Crook, M.·Gumienny, T. L.
View original source ↗Export metadata ↓

Abstract

Transforming Growth Factor beta (TGF-{beta}) signaling helps orchestrate multiple organismal traits in animals by regulating target gene expression. However, how this pathway's transcriptional regulators, called Smads, control target gene expression to generate different traits is not well understood. Using the C. elegans system, we identified the master chromatin remodeler B-lymphocyte maturation protein-1 (BLMP-1, a Kruppel-like zinc finger protein homologous to human PRDM1/BLIMP1) as a partner in Smad-mediated gene expression regulation. Previous research showed BLMP-1/PRDM1 controls organismal traits that the C. elegans TGF-{beta} superfamily member DBL-1 also affects. We identified genetic interactions between the DBL-1 pathway and blmp-1 for these traits. While BLMP-1/PRDM1 and DBL-1 pathway signaling had an additive effect on body size, blmp-1 mutants were epistatic to DBL-1 pathway mutants for male tail development, hermaphrodite gonad development, brood size, lipid levels, movement, and survival traits. We showed DBL-1 signaling transcriptionally regulates blmp-1 expression. We also identified a physical interaction between the DBL-1 pathway Smads and BLMP-1/PRDM1 using yeast-two hybrid analyses. Using bioinformatics and qPCR analysis, we showed that Smads and BLMP-1/PRDM1 regulate expression of common downstream target genes. Our work identifies novel interactions between the DBL-1 signaling pathway and BLMP-1, two conserved major transcriptional regulators, that ultimately influence a spectrum of organismal traits. We propose a model whereby BLMP-1/PRDM1 regulates DBL-1 signaling by acting as a gatekeeper, remodeling the chromatin architecture to control the access of the Smad complex to target genes. Together, our results reveal a direct link between a TGF-{beta} signaling pathway and a PRDM1-family master transcription regulator and offer clues to how they interact to control larval and adult traits. Our work suggests a conserved mechanism of transcriptional control of developmental traits by the Smad-PRDM axis.

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Lakdawala, M. F., Madhu, B., Shaji, S., Crook, M., Gumienny, T. L.. 2026-09-21. DBL-1/BMP signaling pathway Smads and master transcription regulator BLMP-1/PRDM1 interact to regulate organismal traits in Caenorhabditis elegans. https://doi.org/10.64898/2026.09.15.751936

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗
bioRxiv2026

Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypes

Pathogenic ERCC2 variants cause xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or both, yet variant effect scores are usually interpreted only as measures of pathogenicity rather than of which disease mechanism is disrupted. XPD, the ERCC2-encoded TFIIH subunit, functions in both nucleotide excision repair and transcription. Using yeast complementation deep mutational scanning, we measured the effects of nearly all XPD amino acid substitutions. The assay was mechanism-selective: it preferentially reported transcription-associated function, with pronounced intolerance at the p44 interface, whereas many substitutions affecting DNA binding and helicase activity retained near-wild-type fitness. Accordingly, TTD variants had much lower fitness than XP variants. Computational predictors discriminated pathogenic from benign variants similarly across phenotypes, but the DMS distinguished XP from TTD variants better than all 73 predictors tested. Phenotype-specific ACMG/AMP calibration provided evidence in both directions for TTD but mainly pathogenic evidence for XP. Thus, the selectivity of functional assays, often viewed as a limitation, can reveal disease mechanisms and support phenotype-aware variant interpretation.

genetics↗
bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗